Safety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic Asthma

Summary

This study will evaluate the safety and efficacy of QAX576 against asthma attacks in adults with moderate persistent allergic asthma

Timeline

Start

2008-01

Primary completion

2008-12

Completion

—

Outcome

Outcome not reported

Stopped: “Due to the lack of enrolment and complexity of design, this study in asthma was terminated. No subjects have been dosed for this study.”

Drugs

Indications